96914-00-0

Basic information

• Product Name: 5-oxoprolinal
• Synonyms: 5-oxoprolinal
• CAS NO: 96914-00-0
• Molecular Formula: C5H7 N O2
• Molecular Weight: 113.11
• Mol File: 96914-00-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 330.2°Cat760mmHg
• Flash Point: 176.1°C
• Appearance: /
• Density: 1.287g/cm³
• Vapor Pressure: 0.000168mmHg at 25°C
• Refractive Index: 1.563
• CAS DataBase Reference: 5-oxoprolinal(CAS DataBase Reference)
• NIST Chemistry Reference: 5-oxoprolinal(96914-00-0)
• EPA Substance Registry System: 5-oxoprolinal(96914-00-0)

Safety Data

• Hazardous Substances Data: 96914-00-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C5H7NO2/c7-3-4-1-2-5(8)6-4/h3-4H,1-2H2,(H,6,8)/t4-/m0/s1

Upstream product

• 62400-75-3 pyroglutamol 
• 4042-36-8 D-pyrrolidone-5-carboxylic acid 
• 185303-87-1 tert-butyl (S)-2-formyl-5-oxopyrrolidine-1-carboxylate 
• 98-79-3 L-Pyroglutamic acid 
• 1298024-11-9 (5S)-pyrrolidin-2-one-5-carbothioic acid ethyl ester 
• 1298023-90-1 (5S)-N-(tert-butyloxycarbonyl)pyrrolidin-2-one-5-carbothioic acid ethyl ester 

Downstream Products

• 128899-30-9 (R)-5-(((tert-butyldimethylsilyl)oxy)methyl)pyrrolidin-2-one 

Relevant articles and documents

AMIDE DERIVATIVE INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF

An amide derivative inhibitor and a preparation method and an application thereof. Specifically relating to the compound shown in general formula (I), a preparation method for same, a pharmaceutical composition comprising said compound, and an application of same as an ASK inhibitor for the treatment of neurodegenerative disease, cardiovascular disease, inflammation, autoimmune and metabolic disease, each of the substituents in the general formula (I) being as defined in the description.

Quinoline-based compound and selective androgen receptor agonist comprising the same

Provided are a novel quinoline-based compound, a pharmaceutical composition containing the quinoline-based compound, and a method for producing the quinoline-based compound. The quinoline-based compound acts on an androgen receptor to increase activities of the androgen receptor, and thus can be favorably used as an agent for treating and preventing diseases or conditions, in which the increased activities of the androgen can lead to improvement of symptoms or the responsiveness to treatment, for example, various hormone-related diseases of the male or female, muscle-wasting disease, osteoporosis, and the like.COPYRIGHT KIPO 2016